Automate citation and reference management, aid research with text and data mining, and securely store and share documents.
15M visits/mo+13.2%#12 Productivity & Office
$1Starting price
9.8KMonthly visits
17Popularity
About Immunai
Immunai is a transformative force in the field of immunotherapy, leveraging advanced technologies to map the immune system with unparalleled precision. At its core, Immunai aims to revolutionize the development of immunomodulatory therapeutics through its proprietary platform, AMICA™. Designed for biopharmaceutical companies and academic institutions, Immunai simplifies the complex process of drug discovery and development by integrating multi-omic single-cell analysis with machine learning and functional genomics. This approach not only accelerates the discovery of new therapeutic targets but also enhances our understanding of immune system mechanisms at a granular level. Key Features: AMICA™ Platform: A comprehensive immune cell atlas that combines multi-omic data from single cells to provide a detailed view of the immune system. Data Engineering: Advanced data handling capabilities that manage and analyze large volumes of multi-omic data. Machine Learning: Utilizes cutting-edge AI to interpret complex biological data and uncover patterns that guide therapeutic discovery. Functional Genomics and Experimental Immunology: Integrates experimental approaches with genomic data to validate findings and accelerate therapeutic development. In Vitro Model Systems: Supports the simulation and testing of immune responses, facilitating rapid advancements in immunotherapy.
Immunai (United States)
United States · Founded 2018
- Founded
- 2018
- Headquarters
- United States
Key features
- AMICA™ Platform
- Data Engineering
- Machine Learning
- Functional Genomics and Experimental Immunology
- In Vitro Model Systems
- Advanced data handling capabilities
Use cases
- Biopharmaceutical companies for target discovery and therapeutic development
- Academic research institutions for advanced studies in immunology and genomics
- Drug developers and immunologists to streamline the drug development process and identify new therapeutic targets
Pros
- Maps the immune system at unprecedented scale and resolution using multi-omic single-cell analysis
- Integrates AMICA™, one of the world’s largest immune-focused harmonized single-cell databases
- Supports end-to-end drug discovery and development workflows from target identification to clinical trial optimization
- Leverages advanced machine learning and functional genomics to validate and refine therapeutic hypotheses
- Partners with leading biopharmaceutical companies and research institutions for collaborative therapeutic advancements
Cons
- Requires high-quality clinical and preclinical samples for optimal data generation and analysis
- Complexity of multi-omic data integration may pose challenges for smaller research teams without specialized expertise
- Dependent on continuous updates to the AMICA™ database to maintain accuracy and relevance of insights
Frequently asked questions about Immunai
What is Immunai and what does it do?
Immunai is a biotechnology company focused on mapping the immune system at unprecedented scale and resolution to facilitate the development of next-generation immune-related therapeutics. It partners with biopharmaceutical companies and research institutions to discover and advance novel therapeutics.
Who is Immunai designed for?
Immunai is designed for biopharmaceutical companies and academic institutions involved in drug discovery and development, particularly in the field of immunotherapy.
What is the AMICA™ platform?
The AMICA™ platform is Immunai's proprietary system that integrates multi-omic single-cell analysis with machine learning and functional genomics to generate a uniform single-cell data foundation. It is used to transform complex therapeutic questions into actionable recommendations.
How does Immunai support drug development?
Immunai supports decision-making along the drug discovery and development journey by providing solutions for target discovery, preclinical evaluation, and clinical trial optimization. It helps reduce risks and accelerate progress through data-driven insights.
What kind of data does Immunai generate?
Immunai generates high-quality, multi-omic data from clinical and preclinical samples using advanced wet lab and computational pipelines. This data is transformed into a uniform single-cell data foundation with unmatched resolution.
How can I partner with Immunai?
Immunai partners with top biopharmaceutical companies and research institutions to discover and advance novel therapeutics. Interested parties can contact Immunai through their website to explore collaboration opportunities.
Immunai traffic & engagement
immunai.com · third-party estimates from Similarweb
Data as of Sep 2026Full AI website ranking →
Monthly visits · Sep 20269.8K-27.5% MoM12-month high 14K (Aug 2026)
Rank among AI websites#4,461▼ 386 vs last monthof 8,652 tools on aitoolnavio™
Top marketUnited States79.1%Top 3 countries bring 100% of visits
Average visit2m 3sLonger than 77% of AI sites
Pages per visit2.39More than 68% of AI sites
Bounce rate42%Leave after one page · lower is better
Similarweb global rank#2,013,505#570,591 in United States
Traffic trend
Last 4 months · grows by one month every month
- Jun 20266.4K
- Jul 20268.9K+39.1%
- Aug 202614K+52.7%
- Sep 20269.8K−27.5%
Top countries
Share of visits · estimated visits
Visits sent by AI assistants
How people reach this site from other AI tools
22 a month · 0.2% of all visits
Compared with similar tools
Productivity & Office · Sep 2026
Traffic figures are third-party estimates, good for scale and trends; they can differ from a company's own numbers. Updated monthly.
